Inivata
is a North Carolina-based biotechnology company that develops and distributes ctDNA genome-scale diagnostics tools for the treatment of cancer... Read moreInivata
is a North Carolina-based biotechnology company that develops and distributes ctDNA genome-scale diagnostics tools for the treatment of cancer... Read more
News
Jul 06, 2023
Inivata Blog
Inivata Blog NIHR Uses Inivata Technology in Breast Cancer Study
Jan 05, 2023
Inivata Blog
Inivata Blog Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
Jan 05, 2023
Inivata Blog
Inivata Blog Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
Jan 05, 2023
Inivata Blog
Inivata Blog Development of a Standardized, DNA-Based Next-Generation Sequencing Assay for Assessment of Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
Sep 12, 2022
Inivata Blog
Inivata Blog Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
Sep 12, 2022
Inivata Blog
Inivata Blog Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma
Sep 07, 2022
FinanzNachrichten
Inivata: Inivata and Collaborators to Present New Data to Support the Application of RaDaR MRD Assay Across Tumor Types at ESMO Congress 2022
Jun 22, 2022
NS Medical Devices
Inivata: Inivata and Collaborators Announce New Data Demonstrating Clinical Potential of its RaDaR MRD Test in HR+ HER2- Breast Cancer
Jun 22, 2022
Medical Device Network
Inivata: Inivata reports positive data from breast cancer assay study
Jun 08, 2022
Inivata Blog
Inivata Blog Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Inivata Competitors
1
2
3
4
5
6
7
8
9
10